Literature DB >> 24123885

Perspectives on RAGE signaling and its role in cardiovascular disease.

M Michael Cohen1.   

Abstract

RAGE stands for Receptor of Advanced Glycation Endproducts. The two main topics discussed are (1) the nature of RAGE signaling and (2) its role in cardiovascular disease. RAGE may occur in membrane-bound form or in secretory form. RAGE signaling involves multiple ligands: (1) several AGEs (2) amyloid β pecursor protein (APP), (3) high mobility group box 1 (HMGB1), (4) S100A4, (5) S100A8/A9, and (6) S100A12, which are calcium-binding proteins, and (7) S100B, a glial-derived protein. RAGE ligands and various diseases involving RAGE signaling are summarized in tabular form.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  AGEs; Alzheimer disease; HMGB1; RAGE signaling; cancer; cardiovascular disease; diabetes mellitus; inflammation; ischemia-reperfusion injury to the heart; membrane-bound RAGE; renal disease; secretory RAGE

Mesh:

Substances:

Year:  2013        PMID: 24123885     DOI: 10.1002/ajmg.a.36181

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  12 in total

1.  RAGE deficiency attenuates the protective effect of Lidocaine against sepsis-induced acute lung injury.

Authors:  Zhuo Zhang; Jie Zhou; Changli Liao; Xiaobing Li; Minghua Liu; Daqiang Song; Xian Jiang
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

Review 2.  Role of RAGE in Alzheimer's Disease.

Authors:  Zhiyou Cai; Nannuan Liu; Chuanling Wang; Biyong Qin; Yingjun Zhou; Ming Xiao; Liying Chang; Liang-Jun Yan; Bin Zhao
Journal:  Cell Mol Neurobiol       Date:  2015-07-15       Impact factor: 5.046

3.  Innate immunity sensors participating in pathophysiology of joint diseases: a brief overview.

Authors:  Jiri Gallo; Milan Raska; Yrjo T Konttinen; Christophe Nich; Stuart B Goodman
Journal:  J Long Term Eff Med Implants       Date:  2014

4.  Advanced glycation endproducts induce apoptosis of endothelial progenitor cells by activating receptor RAGE and NADPH oxidase/JNK signaling axis.

Authors:  Jianfei Chen; Jun Jing; Shiyong Yu; Minbao Song; Hu Tan; Bin Cui; Lan Huang
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

5.  Persistent Increase in Microglial RAGE Contributes to Chronic Stress-Induced Priming of Depressive-like Behavior.

Authors:  Tina C Franklin; Eric S Wohleb; Yi Zhang; Manoela Fogaça; Brendan Hare; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2017-07-21       Impact factor: 13.382

Review 6.  Role of receptor for advanced glycation end products (RAGE) in liver disease.

Authors:  Sho-ichi Yamagishi; Takanori Matsui
Journal:  Eur J Med Res       Date:  2015-02-11       Impact factor: 2.175

7.  Deficiency in Calcium-Binding Protein S100A4 Impairs the Adjuvant Action of Cholera Toxin.

Authors:  Jia-Bin Sun; Jan Holmgren; Maximilian Larena; Manuela Terrinoni; Yu Fang; Anne R Bresnick; Zou Xiang
Journal:  Front Immunol       Date:  2017-09-11       Impact factor: 7.561

8.  Remote Ischemic Postconditioning Protects against Myocardial Ischemia-Reperfusion Injury by Inhibition of the RAGE-HMGB1 Pathway.

Authors:  Xiangming Wang; Junhong Wang; Tiantian Tu; Zakaria Iyan; Deeraj Mungun; Zhijian Yang; Yan Guo
Journal:  Biomed Res Int       Date:  2018-01-23       Impact factor: 3.411

9.  Endogenous Secretory Receptor for Advanced Glycation End Products Protects Endothelial Cells from AGEs Induced Apoptosis.

Authors:  Guomin Yang; Yinqiong Huang; Xiaohong Wu; Xiahong Lin; Jinting Xu; Xiaoyu Chen; Xuefeng Bai; Qiulan Li
Journal:  Biomed Res Int       Date:  2018-04-10       Impact factor: 3.411

10.  Characterization of advanced glycation end products and their receptor (RAGE) in an animal model of myocardial infarction.

Authors:  Bianca de Moraes Fracasso; Juliana Oliveira Rangel; Alessandra Gonçalves Machado; Fernanda Severo Curuja; Amanda Lopes; Virgílio Olsen; Nadine Clausell; Andreia Biolo; Luis Eduardo Rohde; Michael Andrades
Journal:  PLoS One       Date:  2019-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.